mRNA |
temsirolimus |
CTRPv2 |
pan-cancer |
AAC |
-0.037 |
0.5 |
mRNA |
tanespimycin:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.029 |
0.5 |
mRNA |
KIN001-055 |
GDSC1000 |
pan-cancer |
AAC |
0.025 |
0.5 |
mRNA |
681640 |
GDSC1000 |
pan-cancer |
AAC |
-0.027 |
0.5 |
mRNA |
WZ3105 |
GDSC1000 |
pan-cancer |
AAC |
-0.022 |
0.5 |
mRNA |
FSC231 |
CTRPv2 |
pan-cancer |
AAC |
0.055 |
0.5 |
mRNA |
isoliquiritigenin |
CTRPv2 |
pan-cancer |
AAC |
-0.049 |
0.5 |
mRNA |
ISOX:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.026 |
0.5 |
mRNA |
Salubrinal |
GDSC1000 |
pan-cancer |
AAC |
-0.037 |
0.5 |
mRNA |
Panobinostat |
CCLE |
pan-cancer |
AAC |
-0.03 |
0.5 |